Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Cupistem for Crohn's Fistula
NCT01011244Phase 2Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- Feb 2010
- Primary completion
- Sep 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose-derived mesenchymal stem cell in Crohn's disease, sponsored by Anterogen Co., Ltd.. Started Feb 2010; status: completed.
02
Drugs
adipose-derived mesenchymal stem cell
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01011244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011244.